Analyst Ratings for Mineralys Therapeutics, Inc. (MLYS)
MLYS Rating Summary
MLYS Price Target Summary
- Highest: $56.00 (H.C. Wainwright)
- Lowest: $30.00 (Jefferies)
- Average: $47.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.67 (+76%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
Avg. $ Target:
$47.67 (+76%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/27/2026 | TD Cowen | Tara Bancroft | New Coverage | Buy (N/A) |
N/A (N/A) |
27.51 (27.09) |
-1.53% | Details |
| 6/11/2025 | Jefferies » Updated 6/1/2026 |
Dennis Ding | New Coverage | Hold (N/A) |
30.00 (N/A) |
16.19 (27.09) |
67.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
